|
|||||
|
|
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers |
|
| Authors: | Dugoff Lorraine,Cuckle Howard S,Hobbins John C,Malone Fergal D,Belfort Michael A,Nyberg David A,Comstock Christine H,Saade George R,Eddleman Keith A,Dar Peer,Craigo Sabrina D,Timor-Tritsch Ilan E,Carr Steven R,Wolfe Honor M,D'Alton Mary E FaSTER Trial Research Consortium |
| Affiliation: | a Department of Obstetrics and Gynecology, University of Colorado at Denver Health Sciences Center, Aurora, CO b Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY c Royal College of Surgeons in Ireland, Dublin, Ireland d Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT e Swedish Medical Center, Seattle, WA f William Beaumont Medical Center, Royal Oak, MI g Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX h Mount Sinai School of Medicine, Obstetrics, Gynecology and Reproductive Medicine, New York, NY i Department of Obstetrics and Gynecology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY j Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, MA k New York University School of Medicine, New York, NY l Brown University School of Medicine, Providence, RI m University of North Carolina Medical Center, Chapel Hill, NC |
| Abstract: | |
| Keywords: | alpha-fetoprotein fetal loss inhibin A pregnancy-associated plasma protein A unconjugated estriol |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |